Analysis-Novo's stumbles burnish Lilly's widening lead in weight-loss drugs
By Maggie Fick and Bhanvi Satija LONDON, Feb 24 (Reuters) - With U.S. arch rival Eli Lilly streaking...
24th February, 2026
By Maggie Fick and Bhanvi Satija LONDON, Feb 24 (Reuters) - With U.S. arch rival Eli Lilly streaking...
24th February, 2026
By Crispian Balmer ROME, Feb 23 (Reuters) - Cuban doctors are essential to keeping local hospitals r...
23rd February, 2026
BERLIN, Feb 23 (Reuters) - German pharmaceutical company Bayer said on Monday that it had filed a la...
23rd February, 2026
Feb 23 (Reuters) - Novo Nordisk's next-generation weight-loss drug CagriSema was less effective than...
23rd February, 2026
Feb 23 (Reuters) - Novo Nordisk shares fell more than 15% on Monday, wiping away the last gains Wego...
23rd February, 2026
COPENHAGEN, Feb 23 (Reuters) - Novo Nordisk said on Monday its experimental obesity drug CagriSema d...
23rd February, 2026
Feb 23 (Reuters) - Indian IT services company LTIMindtree on Monday said it has won a $100 million d...
23rd February, 2026
Feb 20 (Reuters) - Sonova's full year revenue will come at the lower end of its 2025/2026 forecast r...
20th February, 2026
Feb 17 (Reuters) - The European Commission has approved a higher dose of Novo Nordisk's popular weig...
17th February, 2026

Feb 17 (Reuters) - Medtronic surpassed Wall Street expectations for third-quarter profit on Tuesday,...
17th February, 2026
MILAN, Feb 16 (Reuters) - Exor, the Agnelli family's investment vehicle, and the founder of Lifenet...
16th February, 2026

Feb 14 (Reuters) - Medecins Sans Frontieres has halted "non-critical" medical activities at a major...
14th February, 2026